{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:12:41Z","timestamp":1783926761551,"version":"3.55.0"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The author extends the appreciation to the Deanship of Postgraduate Studies and Scientific Research at Majmaah University for funding this research work through the project number (ICR-2026-XXX)."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41417-026-01051-6","type":"journal-article","created":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T19:58:22Z","timestamp":1781380702000},"page":"612-623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis B virus\u2013induced hepatocellular carcinoma: HBx-associated epigenetic mechanisms and therapeutic opportunities"],"prefix":"10.1038","volume":"33","author":[{"given":"Atahar","family":"Husein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4671-4995","authenticated-orcid":false,"given":"Azfar","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Azhar","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaser E.","family":"Alqurashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esam S.","family":"Al-Malki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed M.","family":"Naiyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Arif","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohiuddin Khan","family":"Warsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"1051_CR1","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","volume":"72","author":"AG Singal","year":"2020","unstructured":"Singal AG, Lampertico P, Nahon P. Epidemiology and surveillance for hepatocellular carcinoma: New trends. J Hepatol. 2020;72:250\u201361.","journal-title":"J Hepatol"},{"key":"1051_CR2","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal AG, Kanwal F, Llovet JM. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol. 2023;20:864\u201384.","journal-title":"Nat Rev Clin Oncol"},{"key":"1051_CR3","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.jhep.2017.03.011","volume":"67","author":"P Bertuccio","year":"2017","unstructured":"Bertuccio P, Turati F, Carioli G, Rodriguez T, La Vecchia C, Malvezzi M, et al. Global trends and predictions in hepatocellular carcinoma mortality. J Hepatol. 2017;67:302\u20139.","journal-title":"J Hepatol"},{"key":"1051_CR4","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jhep.2017.09.016","volume":"68","author":"N Fujiwara","year":"2018","unstructured":"Fujiwara N, Friedman SL, Goossens N, Hoshida Y. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J Hepatol. 2018;68:526\u201349.","journal-title":"J Hepatol"},{"key":"1051_CR5","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1200\/JCO.2015.64.7412","volume":"34","author":"JL Petrick","year":"2016","unstructured":"Petrick JL, Kelly SP, Altekruse SF, McGlynn KA, Rosenberg PS. Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030. J Clin Oncol. 2016;34:1787\u201394.","journal-title":"J Clin Oncol"},{"key":"1051_CR6","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","volume":"82","author":"B Sangro","year":"2025","unstructured":"Sangro B, Argemi J, Ronot M, Paradis V, Meyer T, Mazzaferro V, et al. EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma. J Hepatol. 2025;82:315\u201374.","journal-title":"J Hepatol"},{"key":"1051_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06347-z","volume":"23","author":"P Lin","year":"2025","unstructured":"Lin P, Qin Q, Gan X, Pang J, Wen R, He Y, et al. Integrating single-cell and bulk RNA sequencing data to characterize the heterogeneity of glycan-lipid metabolism polarization in hepatocellular carcinoma. J Transl Med. 2025;23:358.","journal-title":"J Transl Med"},{"key":"1051_CR8","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41417-024-00764-w","volume":"31","author":"F Safri","year":"2024","unstructured":"Safri F, Nguyen R, Zerehpooshnesfchi S, George J, Qiao L. Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications. Cancer Gene Ther. 2024;31:1105\u201312.","journal-title":"Cancer Gene Ther"},{"key":"1051_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14050-z","volume":"11","author":"B Losic","year":"2020","unstructured":"Losic B, Craig AJ, Villacorta-Martin C, Martins-Filho SN, Akers N, Chen X, et al. Intratumoral heterogeneity and clonal evolution in liver cancer. Nat Commun. 2020;11:291.","journal-title":"Nat Commun"},{"key":"1051_CR10","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/hep.32779","volume":"78","author":"Y Lee","year":"2023","unstructured":"Lee Y, Fujiwara N, Yang JD, Hoshida Y. Risk stratification and early detection biomarkers for precision HCC screening. Hepatology. 2023;78:319\u201362.","journal-title":"Hepatology"},{"key":"1051_CR11","doi-asserted-by":"publisher","first-page":"120","DOI":"10.3350\/cmh.2021.0395","volume":"29","author":"YE Chon","year":"2023","unstructured":"Chon YE, Park SY, Hong HP, Son D, Lee J, Yoon E, et al. Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly. Clin Mol Hepatol. 2023;29:120\u201334.","journal-title":"Clin Mol Hepatol"},{"key":"1051_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of Hepatocellular Carcinoma. Hepatology. 2021;73:4\u201313.","journal-title":"Hepatology"},{"key":"1051_CR13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1136\/gutjnl-2020-323153","volume":"71","author":"C P\u00e9neau","year":"2022","unstructured":"P\u00e9neau C, Imbeaud S, La Bella T, Hirsch TZ, Caruso S, Calderaro J, et al. Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma. Gut. 2022;71:616\u201326.","journal-title":"Gut"},{"key":"1051_CR14","doi-asserted-by":"publisher","unstructured":"Wang Y, Yu D, Mei Y, Fu Z, Lin J, Wu D, et al. Long-read sequencing reveals HBV integration patterns and oncogenic impact on early-onset hepatocellular carcinoma. Genome Res. 2025. https:\/\/doi.org\/10.1101\/gr.279889.124.","DOI":"10.1101\/gr.279889.124"},{"key":"1051_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-03999-y","volume":"9","author":"N Hama","year":"2018","unstructured":"Hama N, Totoki Y, Miura F, Tatsuno K, Saito-Adachi M, Nakamura H, et al. Epigenetic landscape influences the liver cancer genome architecture. Nat Commun. 2018;9:1643.","journal-title":"Nat Commun"},{"key":"1051_CR16","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.jcmgh.2022.05.007","volume":"14","author":"M Locatelli","year":"2022","unstructured":"Locatelli M, Quivy J-P, Chapus F, Michelet M, Fresquet J, Maadadi S, et al. HIRA Supports Hepatitis B Virus Minichromosome Establishment and Transcriptional Activity in Infected Hepatocytes. Cell Mol Gastroenterol Hepatol. 2022;14:527\u201351.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"1051_CR17","doi-asserted-by":"publisher","unstructured":"Tanaka H, Diogo Dias J, Jay B, Kita S, Sasaki M, Takeda H, et al. Structural basis of the hepatitis B virus X protein in complex with DDB1. Proc Natl Acad Sci USA. 2025;122. https:\/\/doi.org\/10.1073\/pnas.2421325122.","DOI":"10.1073\/pnas.2421325122"},{"key":"1051_CR18","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nature17170","volume":"531","author":"A Decorsi\u00e8re","year":"2016","unstructured":"Decorsi\u00e8re A, Mueller H, van Breugel PC, Abdul F, Gerossier L, Beran RK, et al. Hepatitis B virus X protein identifies the Smc5\/6 complex as a host restriction factor. Nature. 2016;531:386\u20139.","journal-title":"Nature"},{"key":"1051_CR19","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41421-020-00218-1","volume":"6","author":"B Yang","year":"2020","unstructured":"Yang B, Li B, Jia L, Jiang Y, Wang X, Jiang S, et al. 3D landscape of Hepatitis B virus interactions with human chromatins. Cell Discov. 2020;6:95.","journal-title":"Cell Discov"},{"key":"1051_CR20","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1038\/s42003-025-08443-8","volume":"8","author":"Z Liu","year":"2025","unstructured":"Liu Z, Naz W, Yousaf T, Sun J, Wu Q, Guo M, et al. Viral-Track integrated single-cell RNA-sequencing reveals HBV lymphotropism and immunosuppressive microenvironment in HBV-associated hepatocellular carcinoma. Commun Biol. 2025;8:1030.","journal-title":"Commun Biol"},{"key":"1051_CR21","doi-asserted-by":"publisher","unstructured":"Zanotti S, Boot GF, Coto-Llerena M, Gallon J, Hess GF, Soysal SD et al. The Role of Chronic Liver Diseases in the Emergence and Recurrence of Hepatocellular Carcinoma: An Omics Perspective. Front Med. 2022;9. https:\/\/doi.org\/10.3389\/fmed.2022.888850.","DOI":"10.3389\/fmed.2022.888850"},{"key":"1051_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.18","volume":"2","author":"JM Llovet","year":"2016","unstructured":"Llovet JM, Zucman-Rossi J, Pikarsky E, Sangro B, Schwartz M, Sherman M, et al. Hepatocellular carcinoma. Nat Rev Dis Prim. 2016;2:16018.","journal-title":"Nat Rev Dis Prim"},{"key":"1051_CR23","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3390\/v13020210","volume":"13","author":"WS Mason","year":"2021","unstructured":"Mason WS, Jilbert AR, Litwin S. Hepatitis B Virus DNA Integration and Clonal Expansion of Hepatocytes in the Chronically Infected Liver. Viruses. 2021;13:210.","journal-title":"Viruses"},{"key":"1051_CR24","doi-asserted-by":"publisher","first-page":"5759","DOI":"10.3748\/wjg.v26.i38.5759","volume":"26","author":"S D\u2019souza","year":"2020","unstructured":"D\u2019souza S, Lau KC, Coffin CS, Patel TR. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World J Gastroenterol. 2020;26:5759\u201383.","journal-title":"World J Gastroenterol"},{"key":"1051_CR25","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/cmi.2014.79","volume":"12","author":"A Bertoletti","year":"2015","unstructured":"Bertoletti A, Kennedy PT. The immune tolerant phase of chronic HBV infection: new perspectives on an old concept. Cell Mol Immunol. 2015;12:258\u201363.","journal-title":"Cell Mol Immunol"},{"key":"1051_CR26","doi-asserted-by":"publisher","first-page":"20160274","DOI":"10.1098\/rstb.2016.0274","volume":"372","author":"M Ringehan","year":"2017","unstructured":"Ringehan M, McKeating JA, Protzer U. Viral hepatitis and liver cancer. Philos Philos Trans R Soc B Biol Sci. 2017;372:20160274.","journal-title":"Philos Philos Trans R Soc B Biol Sci"},{"key":"1051_CR27","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1055\/s-0033-1345721","volume":"33","author":"F Guerrieri","year":"2013","unstructured":"Guerrieri F, Belloni L, Pediconi N, Levrero M. Molecular Mechanisms of HBV-Associated Hepatocarcinogenesis. Semin Liver Dis. 2013;33:147\u201356.","journal-title":"Semin Liver Dis"},{"key":"1051_CR28","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/ng.2295","volume":"44","author":"W-K Sung","year":"2012","unstructured":"Sung W-K, Zheng H, Li S, Chen R, Liu X, Li Y, et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet. 2012;44:765\u20139.","journal-title":"Nat Genet"},{"key":"1051_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13591","volume":"7","author":"L-H Zhao","year":"2016","unstructured":"Zhao L-H, Liu X, Yan H-X, Li W-Y, Zeng X, Yang Y, et al. Erratum: Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun. 2016;7:13591.","journal-title":"Nat Commun"},{"key":"1051_CR30","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1016\/j.metabol.2016.01.010","volume":"65","author":"H Zoller","year":"2016","unstructured":"Zoller H, Tilg H. Nonalcoholic fatty liver disease and hepatocellular carcinoma. Metabolism. 2016;65:1151\u201360.","journal-title":"Metabolism"},{"key":"1051_CR31","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1002\/hep.23594","volume":"51","author":"BQ Starley","year":"2010","unstructured":"Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection. Hepatology. 2010;51:1820\u201332.","journal-title":"Hepatology"},{"key":"1051_CR32","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1146\/annurev-med-090514-013832","volume":"67","author":"A Marengo","year":"2016","unstructured":"Marengo A, Rosso C, Bugianesi E. Liver Cancer: Connections with Obesity, Fatty Liver, and Cirrhosis. Annu Rev Med. 2016;67:103\u201317.","journal-title":"Annu Rev Med"},{"key":"1051_CR33","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s00535-016-1273-2","volume":"52","author":"H Takeda","year":"2017","unstructured":"Takeda H, Takai A, Inuzuka T, Marusawa H. Genetic basis of hepatitis virus-associated hepatocellular carcinoma: linkage between infection, inflammation, and tumorigenesis. J Gastroenterol. 2017;52:26\u201338.","journal-title":"J Gastroenterol"},{"key":"1051_CR34","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/1878-0261.13154","volume":"16","author":"J Gallon","year":"2022","unstructured":"Gallon J, Coto-Llerena M, Ercan C, Bianco G, Paradiso V, Nuciforo S, et al. Epigenetic priming in chronic liver disease impacts the transcriptional and genetic landscapes of hepatocellular carcinoma. Mol Oncol. 2022;16:665\u201382.","journal-title":"Mol Oncol"},{"key":"1051_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2022.100482","volume":"4","author":"I Graupera","year":"2022","unstructured":"Graupera I, Isus L, Coll M, Pose E, D\u00edaz A, Vallverd\u00fa J, et al. Molecular characterization of chronic liver disease dynamics: From liver fibrosis to acute-on-chronic liver failure. JHEP Rep. 2022;4:100482.","journal-title":"JHEP Rep"},{"key":"1051_CR36","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.4049\/jimmunol.2400212","volume":"213","author":"A Silwal","year":"2024","unstructured":"Silwal A, Reese B, Patel B, Li Y, Kolev MV, La-Beck NM, et al. TP53 Codon 72 Polymorphism Impacts Macrophage Activation through Reactive Oxygen Species\u2013Dependent Cell Signaling Alterations. J Immunol. 2024;213:1844\u201357.","journal-title":"J Immunol"},{"key":"1051_CR37","doi-asserted-by":"publisher","unstructured":"Tozatto-Maio K, Girot R, Ly ID, Silva Pinto AC, Rocha V, Fernandes F, et al. Polymorphisms in Inflammatory Genes Modulate Clinical Complications in Patients With Sickle Cell Disease. Front Immunol. 2020;11. https:\/\/doi.org\/10.3389\/fimmu.2020.02041.","DOI":"10.3389\/fimmu.2020.02041"},{"key":"1051_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41571-020-0357-3","volume":"17","author":"P Mittal","year":"2020","unstructured":"Mittal P, Roberts CWM. The SWI\/SNF complex in cancer \u2014 biology, biomarkers and therapy. Nat Rev Clin Oncol. 2020;17:435\u201348.","journal-title":"Nat Rev Clin Oncol"},{"key":"1051_CR39","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/ng.3744","volume":"49","author":"R Mathur","year":"2017","unstructured":"Mathur R, Alver BH, San Roman AK, Wilson BG, Wang X, Agoston AT, et al. ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice. Nat Genet. 2017;49:296\u2013302.","journal-title":"Nat Genet"},{"key":"1051_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-016-0201-x","volume":"8","author":"Q-Y Zhao","year":"2016","unstructured":"Zhao Q-Y, Lei P-J, Zhang X, Zheng J-Y, Wang H-Y, Zhao J, et al. Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model. Clin Epigenet. 2016;8:34.","journal-title":"Clin Epigenet"},{"key":"1051_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21707-1","volume":"12","author":"LK Gopi","year":"2021","unstructured":"Gopi LK, Kidder BL. Integrative pan cancer analysis reveals epigenomic variation in cancer type and cell specific chromatin domains. Nat Commun. 2021;12:1419.","journal-title":"Nat Commun"},{"key":"1051_CR42","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jhep.2019.03.007","volume":"71","author":"J Bayo","year":"2019","unstructured":"Bayo J, Fiore EJ, Dominguez LM, Real A, Malvicini M, Rizzo M, et al. A comprehensive study of epigenetic alterations in hepatocellular carcinoma identifies potential therapeutic targets. J Hepatol. 2019;71:78\u201390.","journal-title":"J Hepatol"},{"key":"1051_CR43","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.3390\/biom14091117","volume":"14","author":"AT Davletgildeeva","year":"2024","unstructured":"Davletgildeeva AT, Kuznetsov NA. The Role of DNMT Methyltransferases and TET Dioxygenases in the Maintenance of the DNA Methylation Level. Biomolecules. 2024;14:1117.","journal-title":"Biomolecules"},{"key":"1051_CR44","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.3390\/cells9102321","volume":"9","author":"A Claveria-Cabello","year":"2020","unstructured":"Claveria-Cabello A, Colyn L, Arechederra M, Urman JM, Berasain C, Avila MA, et al. Epigenetics in Liver Fibrosis: Could HDACs be a Therapeutic Target? Cells. 2020;9:2321.","journal-title":"Cells"},{"key":"1051_CR45","doi-asserted-by":"publisher","first-page":"e55761","DOI":"10.1371\/journal.pone.0055761","volume":"8","author":"M-A Song","year":"2013","unstructured":"Song M-A, Tiirikainen M, Kwee S, Okimoto G, Yu H, Wong LL. Elucidating the Landscape of Aberrant DNA Methylation in Hepatocellular Carcinoma. PLoS One. 2013;8:e55761.","journal-title":"PLoS One"},{"key":"1051_CR46","doi-asserted-by":"publisher","first-page":"013","DOI":"10.36283\/PJMD10-2\/013","volume":"10","author":"R Khan","year":"2021","unstructured":"Khan R, Zakir U, Naqvi F-U-H. Aberrant DNA methylation in human hepatocellular carcinoma. Pak J Med Dent. 2021;10:013. https:\/\/doi.org\/10.36283\/PJMD10-2\/013.","journal-title":"Pak J Med Dent"},{"key":"1051_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-04895-6","volume":"13","author":"D Sun","year":"2022","unstructured":"Sun D, Gan X, Liu L, Yang Y, Ding D, Li W, et al. DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334. Cell Death Dis. 2022;13:446.","journal-title":"Cell Death Dis"},{"key":"1051_CR48","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1053\/j.gastro.2013.08.055","volume":"145","author":"K Revill","year":"2013","unstructured":"Revill K, Wang T, Lachenmayer A, Kojima K, Harrington A, Li J, et al. Genome-Wide Methylation Analysis and Epigenetic Unmasking Identify Tumor Suppressor Genes in Hepatocellular Carcinoma. Gastroenterology. 2013;145:1424\u20131435.e25.","journal-title":"Gastroenterology"},{"key":"1051_CR49","doi-asserted-by":"publisher","first-page":"9858","DOI":"10.3390\/ijms22189858","volume":"22","author":"D Zhang","year":"2021","unstructured":"Zhang D, Guo S, Schrodi SJ. Mechanisms of DNA Methylation in Virus-Host Interaction in Hepatitis B Infection: Pathogenesis and Oncogenetic Properties. Int J Mol Sci. 2021;22:9858.","journal-title":"Int J Mol Sci"},{"key":"1051_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/bib\/bbw094","volume":"19","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Huang Q, Ding Z, Liu T, Xue C, Sang X, et al. Genome-wide DNA methylation analysis identifies candidate epigenetic markers and drivers of hepatocellular carcinoma. Brief Bioinform. 2018;19:101\u20138. https:\/\/doi.org\/10.1093\/bib\/bbw094.","journal-title":"Brief Bioinform"},{"key":"1051_CR51","doi-asserted-by":"publisher","unstructured":"Wu X-M, Xi Z-F, Lu J, Wang X-Z, Zhang T-Q, Huang X-Y, et al. Genetic single nucleotide polymorphisms (GSNPs) in the DNA repair genes and hepatocellular carcinoma related to aflatoxin B1 among Guangxiese population. In: Genetic Polymorphisms. IntechOpen; 2017. https:\/\/doi.org\/10.5772\/intechopen.69530.","DOI":"10.5772\/intechopen.69530"},{"key":"1051_CR52","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.jhep.2012.02.035","volume":"57","author":"P Nahon","year":"2012","unstructured":"Nahon P, Zucman-Rossi J. Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis. J Hepatol. 2012;57:663\u201374.","journal-title":"J Hepatol"},{"key":"1051_CR53","doi-asserted-by":"publisher","first-page":"559","DOI":"10.3390\/v15020559","volume":"15","author":"T-H Yang","year":"2023","unstructured":"Yang T-H, Chan C, Yang P-J, Huang Y-H, Lee M-H. Genetic Susceptibility to Hepatocellular Carcinoma in Patients with Chronic Hepatitis Virus Infection. Viruses. 2023;15:559.","journal-title":"Viruses"},{"key":"1051_CR54","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ng.3252","volume":"47","author":"K Schulze","year":"2015","unstructured":"Schulze K, Imbeaud S, Letouz\u00e9 E, Alexandrov LB, Calderaro J, Rebouissou S, et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet. 2015;47:505\u201311.","journal-title":"Nat Genet"},{"key":"1051_CR55","doi-asserted-by":"publisher","first-page":"9069","DOI":"10.3748\/wjg.v22.i41.9069","volume":"22","author":"Z-S Niu","year":"2016","unstructured":"Niu Z-S, Niu X-J, Wang W-H. Genetic alterations in hepatocellular carcinoma: An update. World J Gastroenterol. 2016;22:9069.","journal-title":"World J Gastroenterol"},{"key":"1051_CR56","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.hepres.2006.06.004","volume":"36","author":"XD Long","year":"2006","unstructured":"Long XD, Ma Y, Wei YP, Deng ZL. The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatol Res. 2006;36:48\u201355. https:\/\/doi.org\/10.1016\/j.hepres.2006.06.004.","journal-title":"Hepatol Res"},{"key":"1051_CR57","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ejca.2018.02.010","volume":"94","author":"Y-J Chu","year":"2018","unstructured":"Chu Y-J, Yang H-I, Wu H-C, Lee M-H, Liu J, Wang L-Y, et al. Aflatoxin B1 exposure increases the risk of hepatocellular carcinoma associated with hepatitis C virus infection or alcohol consumption. Eur J Cancer. 2018;94:37\u201346.","journal-title":"Eur J Cancer"},{"key":"1051_CR58","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s41048-020-00112-z","volume":"6","author":"Z Wang","year":"2020","unstructured":"Wang Z, Wang W, Wang L. Epigenetic regulation of covalently closed circular DNA minichromosome in hepatitis B virus infection. Biophys Rep. 2020;6:115\u201326.","journal-title":"Biophys Rep"},{"key":"1051_CR59","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s00281-020-00780-6","volume":"42","author":"M Dandri","year":"2020","unstructured":"Dandri M. Epigenetic modulation in chronic hepatitis B virus infection. Semin Immunopathol. 2020;42:173\u201385.","journal-title":"Semin Immunopathol"},{"key":"1051_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104824","volume":"180","author":"Y Xia","year":"2020","unstructured":"Xia Y, Guo H. Hepatitis B virus cccDNA: Formation, regulation and therapeutic potential. Antivir Res. 2020;180:104824.","journal-title":"Antivir Res"},{"key":"1051_CR61","doi-asserted-by":"publisher","first-page":"E5715","DOI":"10.1073\/pnas.1518090112","volume":"112","author":"P Tropberger","year":"2015","unstructured":"Tropberger P, Mercier A, Robinson M, Zhong W, Ganem DE, Holdorf M. Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation. Proc Natl Acad Sci USA. 2015;112:E5715\u2013E5724. https:\/\/doi.org\/10.1073\/pnas.1518090112.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1051_CR62","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1002\/hep.29479","volume":"66","author":"X Hong","year":"2017","unstructured":"Hong X, Kim ES, Guo H. Epigenetic regulation of hepatitis B virus covalently closed circular DNA: Implications for epigenetic therapy against chronic hepatitis B. Hepatology. 2017;66:2066\u201377.","journal-title":"Hepatology"},{"key":"1051_CR63","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.1074\/jbc.M606774200","volume":"282","author":"D Cougot","year":"2007","unstructured":"Cougot D, Wu Y, Cairo S, Caramel J, Renard C-A, L\u00e9vy L, et al. The Hepatitis B Virus X Protein Functionally Interacts with CREB-binding Protein\/p300 in the Regulation of CREB-mediated Transcription. J Biol Chem. 2007;282:4277\u201387.","journal-title":"J Biol Chem"},{"key":"1051_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57637-z","volume":"10","author":"CK Chong","year":"2020","unstructured":"Chong CK, Cheng CYS, Tsoi SYJ, Huang F-Y, Liu F, Fung J, et al. HBV X protein mutations affect HBV transcription and association of histone-modifying enzymes with covalently closed circular DNA. Sci Rep. 2020;10:802.","journal-title":"Sci Rep"},{"key":"1051_CR65","doi-asserted-by":"publisher","first-page":"19975","DOI":"10.1073\/pnas.0908365106","volume":"106","author":"L Belloni","year":"2009","unstructured":"Belloni L, Pollicino T, De Nicola F, Guerrieri F, Raffa G, Fanciulli M, et al. Nuclear HBx binds the HBV minichromosome and modifies the epigenetic regulation of cccDNA function. Proc Natl Acad Sci USA. 2009;106:19975\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1051_CR66","doi-asserted-by":"publisher","first-page":"62","DOI":"10.4161\/15592294.2014.990780","volume":"10","author":"J Huang","year":"2015","unstructured":"Huang J, Wan D, Li J, Chen H, Huang K, Zheng L. Histone acetyltransferase PCAF regulates inflammatory molecules in the development of renal injury. Epigenetics. 2015;10:62\u201371.","journal-title":"Epigenetics"},{"key":"1051_CR67","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.immuni.2016.10.028","volume":"45","author":"JP Scott-Browne","year":"2016","unstructured":"Scott-Browne JP, L\u00f3pez-Moyado IF, Trifari S, Wong V, Chavez L, Rao A, et al. Dynamic Changes in Chromatin Accessibility Occur in CD8+T Cells Responding to Viral Infection. Immunity. 2016;45:1327\u201340.","journal-title":"Immunity"},{"key":"1051_CR68","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2337\/dbi20-0006","volume":"70","author":"A Cui","year":"2021","unstructured":"Cui A, Ding D, Li Y. Regulation of Hepatic Metabolism and Cell Growth by the ATF\/CREB Family of Transcription Factors. Diabetes. 2021;70:653\u201364.","journal-title":"Diabetes"},{"key":"1051_CR69","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1002\/hep.25781","volume":"56","author":"LL Studach","year":"2012","unstructured":"Studach LL, Menne S, Cairo S, Buendia MA, Hullinger RL, Lefran\u00e7ois L, et al. Subset of Suz12\/PRC2 target genes is activated during hepatitis B virus replication and liver carcinogenesis associated with HBV X protein. Hepatology. 2012;56:1240\u201351.","journal-title":"Hepatology"},{"key":"1051_CR70","doi-asserted-by":"publisher","unstructured":"Andrisani O. Epigenetic mechanisms in hepatitis B virus-associated hepatocellular carcinoma. Hepatoma Res. 2021;7. https:\/\/doi.org\/10.20517\/2394-5079.2020.83.","DOI":"10.20517\/2394-5079.2020.83"},{"key":"1051_CR71","doi-asserted-by":"publisher","unstructured":"Tan X, Xun L, Yin Q, Chen C, Zhang T, Shen T. Epigenetic Modifications in HBV-Related Hepatocellular Carcinoma. J Viral Hepat. 2025;32. https:\/\/doi.org\/10.1111\/jvh.14044.","DOI":"10.1111\/jvh.14044"},{"key":"1051_CR72","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jhep.2010.03.025","volume":"53","author":"AM Elsharkawy","year":"2010","unstructured":"Elsharkawy AM, Oakley F, Lin F, Packham G, Mann DA, Mann J. The NF-\u03baB p50:p50:HDAC-1 repressor complex orchestrates transcriptional inhibition of multiple pro-inflammatory genes. J Hepatol. 2010;53:519\u201327.","journal-title":"J Hepatol"},{"key":"1051_CR73","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1158\/0008-5472.CAN-11-3248","volume":"72","author":"NJ-M Raynal","year":"2012","unstructured":"Raynal NJ-M, Si J, Taby RF, Gharibyan V, Ahmed S, Jelinek J, et al. DNA Methylation Does Not Stably Lock Gene Expression but Instead Serves as a Molecular Mark for Gene Silencing Memory. Cancer Res. 2012;72:1170\u201381.","journal-title":"Cancer Res"},{"key":"1051_CR74","doi-asserted-by":"publisher","first-page":"11215","DOI":"10.1073\/pnas.92.24.11215","volume":"92","author":"J Benn","year":"1995","unstructured":"Benn J, Schneider RJ. Hepatitis B virus HBx protein deregulates cell cycle checkpoint controls. Proc Natl Acad Sci USA. 1995;92:11215\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1051_CR75","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/j.molonc.2016.05.006","volume":"10","author":"C Chan","year":"2016","unstructured":"Chan C, Thurnherr T, Wang J, Gallart-Palau X, Sze SK, Rozen S, et al. Global re-wiring of p53 transcription regulation by the hepatitis B virus X protein. Mol Oncol. 2016;10:1183\u201395.","journal-title":"Mol Oncol"},{"key":"1051_CR76","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/5047","volume":"21","author":"EE Cameron","year":"1999","unstructured":"Cameron EE, Bachman KE, My\u00f6h\u00e4nen S, Herman JG, Baylin SB. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet. 1999;21:103\u20137.","journal-title":"Nat Genet"},{"key":"1051_CR77","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1038\/emm.2016.107","volume":"48","author":"S Lee","year":"2016","unstructured":"Lee S, Lee M-J, Zhang J, Yu G-R, Kim D-G. C-terminal-truncated HBV X promotes hepato-oncogenesis through inhibition of tumor-suppressive \u03b2-catenin\/BAMBI signaling. Exp Mol Med. 2016;48:e275\u2013e275.","journal-title":"Exp Mol Med"},{"key":"1051_CR78","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/S0092-8674(00)82001-2","volume":"87","author":"VV Ogryzko","year":"1996","unstructured":"Ogryzko VV, Schiltz RL, Russanova V, Howard BH, Nakatani Y. The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases. Cell. 1996;87:953\u20139.","journal-title":"Cell"},{"key":"1051_CR79","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1016\/j.celrep.2016.08.026","volume":"16","author":"CM Murphy","year":"2016","unstructured":"Murphy CM, Xu Y, Li F, Nio K, Reszka-Blanco N, Li X, et al. Hepatitis B Virus X Protein Promotes Degradation of SMC5\/6 to Enhance HBV Replication. Cell Rep. 2016;16:2846\u201354.","journal-title":"Cell Rep"},{"key":"1051_CR80","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jhep.2021.08.010","volume":"76","author":"K Sekiba","year":"2022","unstructured":"Sekiba K, Otsuka M, Funato K, Miyakawa Y, Tanaka E, Seimiya T, et al. HBx-induced degradation of Smc5\/6 complex impairs homologous recombination-mediated repair of damaged DNA. J Hepatol. 2022;76:53\u201362.","journal-title":"J Hepatol"},{"key":"1051_CR81","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3390\/v16111667","volume":"16","author":"J B\u00e4cher","year":"2024","unstructured":"B\u00e4cher J, Allweiss L, Dandri M. SMC5\/6-Mediated Transcriptional Regulation of Hepatitis B Virus and Its Therapeutic Potential. Viruses. 2024;16:1667.","journal-title":"Viruses"},{"key":"1051_CR82","doi-asserted-by":"publisher","first-page":"25075","DOI":"10.18632\/oncotarget.25308","volume":"9","author":"M Furuta","year":"2018","unstructured":"Furuta M, Tanaka H, Shiraishi Y, Uchida T, Imamura M, Fujimoto A, et al. Characterization of HBV integration patterns and timing in liver cancer and HBV-infected livers. Oncotarget. 2018;9:25075\u201388.","journal-title":"Oncotarget"},{"key":"1051_CR83","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s12250-015-3582-7","volume":"30","author":"Y Tian","year":"2015","unstructured":"Tian Y, Ou JJ. Genetic and epigenetic alterations in hepatitis B virus-associated hepatocellular carcinoma. Virol Sin. 2015;30:85\u201391.","journal-title":"Virol Sin"},{"key":"1051_CR84","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/hep.21467","volume":"45","author":"S Boyault","year":"2007","unstructured":"Boyault S, Rickman DS, de Reyni\u00e8s A, Balabaud C, Rebouissou S, Jeannot E, et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology. 2007;45:42\u201352.","journal-title":"Hepatology"},{"key":"1051_CR85","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.devcel.2019.05.034","volume":"50","author":"S Wang","year":"2019","unstructured":"Wang S, Zhang C, Hasson D, Desai A, SenBanerjee S, Magnani E, et al. Epigenetic Compensation Promotes Liver Regeneration. Dev Cell. 2019;50:43\u201356.e6.","journal-title":"Dev Cell"},{"key":"1051_CR86","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nature23262","volume":"547","author":"A Inoue","year":"2017","unstructured":"Inoue A, Jiang L, Lu F, Suzuki T, Zhang Y. Maternal H3K27me3 controls DNA methylation-independent imprinting. Nature. 2017;547:419\u201324.","journal-title":"Nature"},{"key":"1051_CR87","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/S0002-9440(10)63469-4","volume":"163","author":"B Yang","year":"2003","unstructured":"Yang B, Guo M, Herman JG, Clark DP. Aberrant Promoter Methylation Profiles of Tumor Suppressor Genes in Hepatocellular Carcinoma. Am J Pathol. 2003;163:1101\u20137.","journal-title":"Am J Pathol"},{"key":"1051_CR88","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1002\/hep.27732","volume":"61","author":"A Villanueva","year":"2015","unstructured":"Villanueva A, Portela A, Sayols S, Battiston C, Hoshida Y, M\u00e9ndez-Gonz\u00e1lez J, et al. DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma. Hepatology. 2015;61:1945\u201356.","journal-title":"Hepatology"},{"key":"1051_CR89","doi-asserted-by":"publisher","first-page":"e9749","DOI":"10.1371\/journal.pone.0009749","volume":"5","author":"H Hernandez-Vargas","year":"2010","unstructured":"Hernandez-Vargas H, Lambert M-P, Le Calvez-Kelm F, Gouysse G, McKay-Chopin S, Tavtigian SV, et al. Hepatocellular Carcinoma Displays Distinct DNA Methylation Signatures with Potential as Clinical Predictors. PLoS One. 2010;5:e9749.","journal-title":"PLoS One"},{"key":"1051_CR90","doi-asserted-by":"publisher","first-page":"6531","DOI":"10.3390\/ijms26136531","volume":"26","author":"N Rembia\u0142kowska","year":"2025","unstructured":"Rembia\u0142kowska N, Rekiel K, Urbanowicz P, Mamala M, Marczuk K, Wojtaszek M, et al. Epigenetic Dysregulation in Cancer: Implications for Gene Expression and DNA Repair-Associated Pathways. Int J Mol Sci. 2025;26:6531.","journal-title":"Int J Mol Sci"},{"key":"1051_CR91","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/978-3-642-59696-4_3","volume":"249","author":"JG Herman","year":"2000","unstructured":"Herman JG, Baylin SB. Promoter-region hypermethylation and gene silencing in human cancer. Curr Top Microbiol Immunol. 2000;249:35\u201354. https:\/\/doi.org\/10.1007\/978-3-642-59696-4_3.","journal-title":"Curr Top Microbiol Immunol"},{"key":"1051_CR92","doi-asserted-by":"publisher","first-page":"239","DOI":"10.2217\/epi.09.33","volume":"1","author":"M Ehrlich","year":"2009","unstructured":"Ehrlich M. DNA hypomethylation in cancer cells. Epigenomics. 2009;1:239\u201359.","journal-title":"Epigenomics"},{"key":"1051_CR93","first-page":"65","volume":"20","author":"B-K Oh","year":"2007","unstructured":"Oh B-K, Kim H, Park H-J, Shim Y-H, Choi J, Park C, et al. DNA methyltransferase expression and DNA methylation in human hepatocellular carcinoma and their clinicopathological correlation. Int J Mol Med. 2007;20:65\u201373.","journal-title":"Int J Mol Med"},{"key":"1051_CR94","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cell.2019.08.052","volume":"179","author":"Q Gao","year":"2019","unstructured":"Gao Q, Zhu H, Dong L, Shi W, Chen R, Song Z, et al. Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma. Cell. 2019;179:561\u2013577.e22.","journal-title":"Cell"},{"key":"1051_CR95","doi-asserted-by":"publisher","first-page":"e62828","DOI":"10.1371\/journal.pone.0062828","volume":"8","author":"C Liu","year":"2013","unstructured":"Liu C, Liu L, Chen X, Shen J, Shan J, Xu Y, et al. Decrease of 5-Hydroxymethylcytosine Is Associated with Progression of Hepatocellular Carcinoma through Downregulation of TET1. PLoS One. 2013;8:e62828.","journal-title":"PLoS One"},{"key":"1051_CR96","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1080\/15592294.2018.1481706","volume":"13","author":"K Lubecka","year":"2018","unstructured":"Lubecka K, Flower K, Beetch M, Qiu J, Kurzava L, Buvala H, et al. Loci-specific differences in blood DNA methylation in HBV-negative populations at risk for hepatocellular carcinoma development. Epigenetics. 2018;13:605\u201326.","journal-title":"Epigenetics"},{"key":"1051_CR97","doi-asserted-by":"publisher","first-page":"e110442","DOI":"10.1371\/journal.pone.0110442","volume":"9","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Mao R, Yan R, Cai D, Zhang Y, Zhu H, et al. Transcription of Hepatitis B Virus Covalently Closed Circular DNA Is Regulated by CpG Methylation during Chronic Infection. PLoS One. 2014;9:e110442.","journal-title":"PLoS One"},{"key":"1051_CR98","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","volume":"49","author":"S Reuter","year":"2010","unstructured":"Reuter S, Gupta SC, Chaturvedi MM, Aggarwal BB. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic Biol Med. 2010;49:1603\u201316.","journal-title":"Free Radic Biol Med"},{"key":"1051_CR99","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.jhep.2010.08.021","volume":"54","author":"T-H Um","year":"2011","unstructured":"Um T-H, Kim H, Oh B-K, Kim MS, Kim KS, Jung G, et al. Aberrant CpG island hypermethylation in dysplastic nodules and early HCC of hepatitis B virus-related human multistep hepatocarcinogenesis. J Hepatol. 2011;54:939\u201347.","journal-title":"J Hepatol"},{"key":"1051_CR100","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jare.2012.11.002","volume":"5","author":"A-RN Zekri","year":"2014","unstructured":"Zekri A-RN, Bahnasy AA, Shoeab FEM, Mohamed WS, El-Dahshan DH, Ali FT, et al. Methylation of multiple genes in hepatitis C virus associated hepatocellular carcinoma. J Adv Res. 2014;5:27\u201340.","journal-title":"J Adv Res"},{"key":"1051_CR101","doi-asserted-by":"publisher","unstructured":"Qian Y, Wang J-W, Fang Y, Yuan X-D, Fan Y-C, Gao S, et al. Measurement of Cyclin D2 (CCND2) Gene Promoter Methylation in Plasma and Peripheral Blood Mononuclear Cells and Alpha-Fetoprotein Levels in Patients with Hepatitis B Virus-Associated Hepatocellular Carcinoma. Med Sci Monit. 2020;26. https:\/\/doi.org\/10.12659\/MSM.927444.","DOI":"10.12659\/MSM.927444"},{"key":"1051_CR102","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1053\/j.gastro.2006.01.001","volume":"130","author":"T Pollicino","year":"2006","unstructured":"Pollicino T, Belloni L, Raffa G, Pediconi N, Squadrito G, Raimondo G, et al. Hepatitis B Virus Replication Is Regulated by the Acetylation Status of Hepatitis B Virus cccDNA-Bound H3 and H4 Histones. Gastroenterology. 2006;130:823\u201337.","journal-title":"Gastroenterology"},{"key":"1051_CR103","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.jhep.2015.06.023","volume":"63","author":"L Rivi\u00e8re","year":"2015","unstructured":"Rivi\u00e8re L, Gerossier L, Ducroux A, Dion S, Deng Q, Michel M-L, et al. HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase. J Hepatol. 2015;63:1093\u2013102.","journal-title":"J Hepatol"},{"key":"1051_CR104","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/cr.2018.1","volume":"28","author":"J Yan","year":"2018","unstructured":"Yan J, Chen S-AA, Local A, Liu T, Qiu Y, Dorighi KM, et al. Histone H3 lysine 4 monomethylation modulates long-range chromatin interactions at enhancers. Cell Res. 2018;28:204\u201320.","journal-title":"Cell Res"},{"key":"1051_CR105","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo C-J, Chen L-L, Huarte M. Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 2021;22:96\u2013118.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1051_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0734-4","volume":"16","author":"X Huo","year":"2017","unstructured":"Huo X, Han S, Wu G, Latchoumanin O, Zhou G, Hebbard L, et al. Dysregulated long noncoding RNAs (lncRNAs) in hepatocellular carcinoma: implications for tumorigenesis, disease progression, and liver cancer stem cells. Mol Cancer. 2017;16:165.","journal-title":"Mol Cancer"},{"key":"1051_CR107","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-01188-4","volume":"19","author":"Z Huang","year":"2020","unstructured":"Huang Z, Zhou J-K, Peng Y, He W, Huang C. The role of long noncoding RNAs in hepatocellular carcinoma. Mol Cancer. 2020;19:77.","journal-title":"Mol Cancer"},{"key":"1051_CR108","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.tig.2017.11.005","volume":"34","author":"Q Sun","year":"2018","unstructured":"Sun Q, Hao Q, Prasanth KV. Nuclear Long Noncoding RNAs: Key Regulators of Gene Expression. Trends Genet. 2018;34:142\u201357.","journal-title":"Trends Genet"},{"key":"1051_CR109","doi-asserted-by":"publisher","first-page":"003","DOI":"10.1055\/s-0034-1397344","volume":"35","author":"A Mohr","year":"2015","unstructured":"Mohr A, Mott J. Overview of MicroRNA Biology. Semin Liver Dis. 2015;35:003\u201311.","journal-title":"Semin Liver Dis"},{"key":"1051_CR110","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-016-1085-4","volume":"14","author":"Q Zhang","year":"2016","unstructured":"Zhang Q, Matsuura K, Kleiner DE, Zamboni F, Alter HJ, Farci P. Analysis of long noncoding RNA expression in hepatocellular carcinoma of different viral etiology. J Transl Med. 2016;14:328.","journal-title":"J Transl Med"},{"key":"1051_CR111","doi-asserted-by":"publisher","first-page":"701","DOI":"10.3390\/life12050701","volume":"12","author":"J Yu","year":"2022","unstructured":"Yu J, Zhang H, Zhang Y, Zhang X. Integrated Analysis of the Altered lncRNA, microRNA, and mRNA Expression in HBV-Positive Hepatocellular Carcinoma. Life. 2022;12:701.","journal-title":"Life"},{"key":"1051_CR112","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/hep.29690","volume":"67","author":"AK Singh","year":"2018","unstructured":"Singh AK, Rooge SB, Varshney A, Vasudevan M, Bhardwaj A, Venugopal SK, et al. Global microRNA expression profiling in the liver biopsies of hepatitis B virus\u2013infected patients suggests specific microRNA signatures for viral persistence and hepatocellular injury. Hepatology. 2018;67:1695\u2013709.","journal-title":"Hepatology"},{"key":"1051_CR113","doi-asserted-by":"publisher","unstructured":"Xu J, An P, Winkler CA, Yu Y. Dysregulated microRNAs in Hepatitis B Virus-Related Hepatocellular Carcinoma: Potential as Biomarkers and Therapeutic Targets. Front Oncol. 2020;10. https:\/\/doi.org\/10.3389\/fonc.2020.01271.","DOI":"10.3389\/fonc.2020.01271"},{"key":"1051_CR114","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1089\/omi.2024.0071","volume":"28","author":"K Ramakrishnan","year":"2024","unstructured":"Ramakrishnan K, Vishwakarma R, Dev RR, Raju R, Rehman N. Etiologically Significant microRNAs in Hepatitis B Virus-Induced Hepatocellular Carcinoma. OMICS. 2024;28:280\u201390.","journal-title":"OMICS"},{"key":"1051_CR115","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1016\/j.ejca.2014.07.008","volume":"50","author":"CH Li","year":"2014","unstructured":"Li CH, Xu F, Chow S, Feng L, Yin D, Ng TB, et al. Hepatitis B virus X protein promotes hepatocellular carcinoma transformation through interleukin-6 activation of microRNA-21 expression. Eur J Cancer. 2014;50:2560\u20139.","journal-title":"Eur J Cancer"},{"key":"1051_CR116","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","volume":"133","author":"F Meng","year":"2007","unstructured":"Meng F, Henson R, Wehbe\u2013Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer. Gastroenterology. 2007;133:647\u201358.","journal-title":"Gastroenterology"},{"key":"1051_CR117","doi-asserted-by":"publisher","first-page":"2884","DOI":"10.1172\/JCI63455","volume":"122","author":"W-C Tsai","year":"2012","unstructured":"Tsai W-C, Hsu S-D, Hsu C-S, Lai T-C, Chen S-J, Shen R, et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest. 2012;122:2884\u201397.","journal-title":"J Clin Invest"},{"key":"1051_CR118","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1042\/BST0361220","volume":"36","author":"CL Jopling","year":"2008","unstructured":"Jopling CL. Regulation of hepatitis C virus by microRNA-122. Biochem Soc Trans. 2008;36:1220\u20133.","journal-title":"Biochem Soc Trans"},{"key":"1051_CR119","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/hep.23660","volume":"52","author":"J Huang","year":"2010","unstructured":"Huang J, Wang Y, Guo Y, Sun S. Down-Regulated MicroRNA-152 Induces Aberrant DNA Methylation in Hepatitis B Virus\u2013Related Hepatocellular Carcinoma by Targeting DNA Methyltransferase 1. Hepatology. 2010;52:60\u201370.","journal-title":"Hepatology"},{"key":"1051_CR120","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1056\/NEJMoa0901282","volume":"361","author":"J Ji","year":"2009","unstructured":"Ji J, Shi J, Budhu A, Yu Z, Forgues M, Roessler S, et al. MicroRNA Expression, Survival, and Response to Interferon in Liver Cancer. N Engl J Med. 2009;361:1437\u201347.","journal-title":"N Engl J Med"},{"key":"1051_CR121","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.ccell.2016.03.010","volume":"29","author":"AM Schmitt","year":"2016","unstructured":"Schmitt AM, Chang HY. Long Noncoding RNAs in Cancer Pathways. Cancer Cell. 2016;29:452\u201363.","journal-title":"Cancer Cell"},{"key":"1051_CR122","doi-asserted-by":"publisher","unstructured":"Samudh N, Shrilall C, Arbuthnot P, Bloom K, Ely A. Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular Carcinoma. Front Immunol. 2022;13. https:\/\/doi.org\/10.3389\/fimmu.2022.834650.","DOI":"10.3389\/fimmu.2022.834650"},{"key":"1051_CR123","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.3390\/cancers13133115","volume":"13","author":"V Alfano","year":"2021","unstructured":"Alfano V, Zeisel MB, Levrero M, Guerrieri F. The lncRNAs in HBV-Related HCCs: Targeting Chromatin Dynamics and Beyond. Cancers. 2021;13:3115.","journal-title":"Cancers"},{"key":"1051_CR124","doi-asserted-by":"publisher","first-page":"5227","DOI":"10.7150\/thno.34273","volume":"9","author":"J Feng","year":"2019","unstructured":"Feng J, Yang G, Liu Y, Gao Y, Zhao M, Bu Y, et al. LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer. Theranostics. 2019;9:5227\u201345.","journal-title":"Theranostics"},{"key":"1051_CR125","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1136\/gutjnl-2019-319637","volume":"69","author":"D Salerno","year":"2020","unstructured":"Salerno D, Chiodo L, Alfano V, Floriot O, Cottone G, Paturel A, et al. Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription. Gut. 2020;69:2016\u201324.","journal-title":"Gut"},{"key":"1051_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/srep23521","volume":"6","author":"J-J Hu","year":"2016","unstructured":"Hu J-J, Song W, Zhang S-D, Shen X-H, Qiu X-M, Wu H-Z, et al. HBx-upregulated lncRNA UCA1 promotes cell growth and tumorigenesis by recruiting EZH2 and repressing p27Kip1\/CDK2 signaling. Sci Rep. 2016;6:23521.","journal-title":"Sci Rep"},{"key":"1051_CR127","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1158\/0008-5472.CAN-14-2928","volume":"75","author":"H Zhang","year":"2015","unstructured":"Zhang H, Diab A, Fan H, Mani SKK, Hullinger R, Merle P, et al. PLK1 and HOTAIR Accelerate Proteasomal Degradation of SUZ12 and ZNF198 during Hepatitis B Virus\u2013Induced Liver Carcinogenesis. Cancer Res. 2015;75:2363\u201374.","journal-title":"Cancer Res"},{"key":"1051_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100167","volume":"2","author":"MG Fern\u00e1ndez-Barrena","year":"2020","unstructured":"Fern\u00e1ndez-Barrena MG, Arechederra M, Colyn L, Berasain C, Avila MA. Epigenetics in hepatocellular carcinoma development and therapy: The tip of the iceberg. JHEP Rep. 2020;2:100167.","journal-title":"JHEP Rep"},{"key":"1051_CR129","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1016\/j.ymthe.2018.04.018","volume":"26","author":"L Gailhouste","year":"2018","unstructured":"Gailhouste L, Liew LC, Yasukawa K, Hatada I, Tanaka Y, Nakagama H, et al. Differentiation Therapy by Epigenetic Reconditioning Exerts Antitumor Effects on Liver Cancer Cells. Mol Ther. 2018;26:1840\u201354.","journal-title":"Mol Ther"},{"key":"1051_CR130","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrg.2016.93","volume":"17","author":"PA Jones","year":"2016","unstructured":"Jones PA, Issa J-PJ, Baylin S. Targeting the cancer epigenome for therapy. Nat Rev Genet. 2016;17:630\u201341.","journal-title":"Nat Rev Genet"},{"key":"1051_CR131","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Dawson MA, Kouzarides T. Cancer Epigenetics: From Mechanism to Therapy. Cell. 2012;150:12\u201327.","journal-title":"Cell"},{"key":"1051_CR132","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.cell.2017.10.022","volume":"171","author":"MJ Topper","year":"2017","unstructured":"Topper MJ, Vaz M, Chiappinelli KB, DeStefano Shields CE, Niknafs N, Yen R-WC, et al. Epigenetic Therapy Ties MYC Depletion to Reversing Immune Evasion and Treating Lung Cancer. Cell. 2017;171:1284\u20131300.e21.","journal-title":"Cell"},{"key":"1051_CR133","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","volume":"162","author":"D Roulois","year":"2015","unstructured":"Roulois D, Loo Yau H, Singhania R, Wang Y, Danesh A, Shen SY, et al. DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts. Cell. 2015;162:961\u201373.","journal-title":"Cell"},{"key":"1051_CR134","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.036","volume":"169","author":"KB Chiappinelli","year":"2017","unstructured":"Chiappinelli KB, Strissel PL, Desrichard A, Li H, Henke C, Akman B, et al. Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses. Cell. 2017;169:361.","journal-title":"Cell"},{"key":"1051_CR135","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41568-019-0109-9","volume":"19","author":"PA Jones","year":"2019","unstructured":"Jones PA, Ohtani H, Chakravarthy A, De Carvalho DD. Epigenetic therapy in immune-oncology. Nat Rev Cancer. 2019;19:151\u201361.","journal-title":"Nat Rev Cancer"},{"key":"1051_CR136","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1002\/hep.30091","volume":"68","author":"M Liu","year":"2018","unstructured":"Liu M, Zhang L, Li H, Hinoue T, Zhou W, Ohtani H, et al. Integrative Epigenetic Analysis Reveals Therapeutic Targets to the DNA Methyltransferase Inhibitor Guadecitabine (SGI-110) in Hepatocellular Carcinoma. Hepatology. 2018;68:1412\u201328.","journal-title":"Hepatology"},{"key":"1051_CR137","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01154-x","volume":"13","author":"C Hu","year":"2021","unstructured":"Hu C, Liu X, Zeng Y, Liu J, Wu F. DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application. Clin Epigenet. 2021;13:166.","journal-title":"Clin Epigenet"},{"key":"1051_CR138","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-025-01925-w","volume":"17","author":"M Zhang","year":"2025","unstructured":"Zhang M, Zhou X, Li Z, Zhao T, Miao Y, Liu S, et al. Decitabine regulates the resistance of HCC to sorafenib through demethylation. Clin Epigenet. 2025;17:120.","journal-title":"Clin Epigenet"},{"key":"1051_CR139","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1080\/15592294.2016.1214781","volume":"11","author":"S Jueliger","year":"2016","unstructured":"Jueliger S, Lyons J, Cannito S, Pata I, Pata P, Shkolnaya M, et al. Efficacy and epigenetic interactions of novel DNA hypomethylating agent guadecitabine (SGI-110) in preclinical models of hepatocellular carcinoma. Epigenetics. 2016;11:709\u201320.","journal-title":"Epigenetics"},{"key":"1051_CR140","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1016\/j.molonc.2015.06.002","volume":"9","author":"Y Kuang","year":"2015","unstructured":"Kuang Y, El-Khoueiry A, Taverna P, Ljungman M, Neamati N. Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin. Mol Oncol. 2015;9:1799\u2013814.","journal-title":"Mol Oncol"},{"key":"1051_CR141","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/hep.30133","volume":"68","author":"RA Hlady","year":"2018","unstructured":"Hlady RA, Robertson KD. A Three-Pronged Epigenetic Approach to the Treatment of Hepatocellular Carcinoma. Hepatology. 2018;68:1226\u20138.","journal-title":"Hepatology"},{"key":"1051_CR142","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/pharmaceutics14010209","volume":"14","author":"D Ruzic","year":"2022","unstructured":"Ruzic D, Djokovi\u0107 N, Srdi\u0107-Raji\u0107 T, Echeverria C, Nikolic K, Santibanez JF. Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention. Pharmaceutics. 2022;14:209.","journal-title":"Pharmaceutics"},{"key":"1051_CR143","doi-asserted-by":"publisher","unstructured":"Hao D, Deng F, Shi H, Wang H, Xiao F, Sun C, et al. In vivo inhibitory effect of suberoylanilide hydroxamic acid combined with sorafenib on human hepatocellular carcinoma cells. Brazilian J Pharmaceutical Sci. 2020; 56. https:\/\/doi.org\/10.1590\/s2175-97902019000318254.","DOI":"10.1590\/s2175-97902019000318254"},{"key":"1051_CR144","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.3390\/cancers11101587","volume":"11","author":"K Freese","year":"2019","unstructured":"Freese K, Seitz T, Dietrich P, Lee SML, Thasler WE, Bosserhoff A, et al. Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro. Cancers. 2019;11:1587.","journal-title":"Cancers"},{"key":"1051_CR145","doi-asserted-by":"publisher","unstructured":"Suraweera A, O\u2019Byrne KJ, Richard DJ. Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi. Front Oncol. 2018;8. https:\/\/doi.org\/10.3389\/fonc.2018.00092.","DOI":"10.3389\/fonc.2018.00092"},{"key":"1051_CR146","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.3390\/jcm10081715","volume":"10","author":"MB Zeisel","year":"2021","unstructured":"Zeisel MB, Guerrieri F, Levrero M. Host Epigenetic Alterations and Hepatitis B Virus-Associated Hepatocellular Carcinoma. J Clin Med. 2021;10:1715.","journal-title":"J Clin Med"},{"key":"1051_CR147","doi-asserted-by":"publisher","unstructured":"Kim J, Ha J, Song C, Sajjad MA, Kalsoom F, Kwon H, et al. Sirtuin 2 inhibitor AGK2 exerts antiviral effects by inducing epigenetic suppression of hepatitis B virus covalently closed circular DNA through recruitment of repressive histone lysine methyltransferases and reduction of cccDNA. Front Cell Infect Microbiol. 2025;15. https:\/\/doi.org\/10.3389\/fcimb.2025.1537929.","DOI":"10.3389\/fcimb.2025.1537929"},{"key":"1051_CR148","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1007\/s13105-025-01095-6","volume":"81","author":"B Castell\u00f3-Uribe","year":"2025","unstructured":"Castell\u00f3-Uribe B, L\u00f3pez-Pascual A, Elurbide J, Ad\u00e1n-Villaescusa E, Valbuena-Goiricelaya E, Martinez-Perez LA, et al. Expression landscape of epigenetic genes in human hepatocellular carcinoma. J Physiol Biochem. 2025;81:699\u2013727.","journal-title":"J Physiol Biochem"},{"key":"1051_CR149","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.antiviral.2014.08.015","volume":"111","author":"MH van der Ree","year":"2014","unstructured":"van der Ree MH, van der Meer AJ, de Bruijne J, Maan R, van Vliet A, Welzel TM, et al. Long-term safety and efficacy of microRNA-targeted therapy in chronic hepatitis C patients. Antivir Res. 2014;111:53\u201359.","journal-title":"Antivir Res"},{"key":"1051_CR150","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3390\/ijms25031469","volume":"25","author":"AA Seyhan","year":"2024","unstructured":"Seyhan AA. Trials and Tribulations of MicroRNA Therapeutics. Int J Mol Sci. 2024;25:1469.","journal-title":"Int J Mol Sci"},{"key":"1051_CR151","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s12072-022-10351-6","volume":"16","author":"L Yang","year":"2022","unstructured":"Yang L, Zou T, Chen Y, Zhao Y, Wu X, Li M, et al. Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma. Hepatol Int. 2022;16:741\u201354.","journal-title":"Hepatol Int"},{"key":"1051_CR152","doi-asserted-by":"publisher","unstructured":"Zhang Y, Cao W, Wang S, Zhang L, Li X, Zhang Z, et al. Epigenetic modification of hepatitis B virus infection and related hepatocellular carcinoma. Virulence. 2024;15. https:\/\/doi.org\/10.1080\/21505594.2024.2421231.","DOI":"10.1080\/21505594.2024.2421231"},{"key":"1051_CR153","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.cellimm.2018.12.010","volume":"336","author":"YK Hong","year":"2019","unstructured":"Hong YK, Li Y, Pandit H, Li S, Pulliam Z, Zheng Q, et al. Epigenetic modulation enhances immunotherapy for hepatocellular carcinoma. Cell Immunol. 2019;336:66\u201374.","journal-title":"Cell Immunol"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01051-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01051-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01051-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:02:23Z","timestamp":1783926143000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01051-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":153,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1051"],"URL":"https:\/\/doi.org\/10.1038\/s41417-026-01051-6","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"3 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}